
A moderate metal-binding hydrazone meets the criteria for a bioinorganic approach towards Parkinson's disease: Therapeutic potential, blood-brain barrier crossing evaluation and preliminary toxicological studies
Keywords: Parkinson's disease; α-Synuclein; Metal hypothesis; Copper; MPAC; Wistar rats;